DOCSLIB.ORG

2018 Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 Annual Report 2018 EDUCATION 2018 COLLABORATION Level 14, 477 Pitt Street ADVOCACY Sydney NSW 2000 GPO Box 4708 Sydney NSW 2001 EDUCATION RESEARCH COLLABORATIONADVOCACY Telephone: (02) 8063 4100 RESEARCH Facsimile: (02) 8063 4101 www.cosa.org.au 1 - 1 ANNUAL REPORT 2017 SECTION INDEX COSA BOARD + COSA REPORTS 3 C COSA GROUP REPORTS 12 A AFFILIATED ORGANISATION REPORTS 24 O OTHER REPORTS 52 $ FINANCIAL STATEMENTS 54 PRESIDENTS OF COSA 1973 - 1976 Mr WB Fleming AM - Deceased MBBS FRACS FRCS(Eng) FACS 1976 - 1979 Professor L Atkinson - Deceased FRCS FRACS FACR 1979 - 1981 Dr RP Melville- Deceased MBBS FRCS FRACS FACS 1981 - 1983 Professor MHN Tattersall AO MA MD MSc FRCP FRACP 1983 - 1985 Professor GJ Clunie - Deceased CHM(Ed) FRCS(Ed) FRCS FRACS 1985 - 1987 Dr JVM Coppleson AO - Deceased MBBS(Hons) MD FRCOG FRACOG 1988 - 1989 Dr JA Levi MBBS FRACP 1990 - 1991 Professor RM Fox AM BSc(Med) PhD MBBS FRACP 1992 - 1993 Professor WH McCarthy AM MEd FRACS 1994 - 1995 Professor AS Coates AM MD FRACP 1996 - 1997 Professor RJS Thomas MBBS MS FRACS FRCS 1998 - 1999 Professor H Ekert AM MBBS MD FRACP FRCPA 2000 - 2001 Professor J Zalcberg OAM MBBS PhD FRACP GAICD MRACMA 2002 - 2003 Professor L Kenny AO MBBS FRANZCR 2004 - 2005 Dr S Ackland MBBS FRACP 2006 – Jul 2006 Professor D Currow BMed FRACP MPH 2006 - 2008 Professor D Goldstein MBBS FRACP FRCP 2009 - 2010 Professor GB Mann MBBS PhD FRACS 2011 - 2012 Professor B Koczwara AM BM BS FRACP MBioethics FAICD 2013 - 2014 Professor SV Porceddu BSc MBBS (Hons) MD FRANZCR 2015 - 2016 Professor M Krishnasamy BA RGN DipN MSc PhD 2017 – 2018 Professor P Butow AM BA(Hons) Dip Ed MClinPsych MPH PhD ANNUAL REPORT 2017 COSA VISION AND MISSION COSA achieves QUALITY this by: • supporting the professional MULTIDISCIPLINARY and educational needs of cancer health professionals CANCER CARE FOR ALL • enhancing cancer care and control through network development The overarching mission of COSA is to improve • advocating for improvements cancer care and control through collaboration. in cancer care and control • facilitating research across the spectrum of cancer COSA MEMBERSHIP As at 31 December 2018 there were 777 registered members of COSA. Members are drawn from the many disciplines in medicine engaged in cancer treatment and from associated research, patient care and support areas. They come from universities, private practice, government and private laboratories and other health services. There are 2 types of postgraduate degree or fellowship for admission as an honorary member. from a recognised College or Society This membership category is offered COSA membership: that is relevant to the vision and to past Presidents of COSA and Individual membership – mission of COSA. nominees and must be approved be the COSA Board. COSA Members • Non-medical members have a specific interest in oncology and a Organisational membership – 4 STUDENT MEMBERS Affiliated and Associated professional qualification relevant to Organisations COSA’s vision and mission. A person who is undertaking full time undergraduate or post-graduate The categories of 2 RETIREE MEMBERS studies with a stream of cancer care membership of COSA are: A person who has retired from their is eligible as a student member. professional employment, who has Documented evidence of their status is required upon application annually 1 ORDINARY MEMBERS held COSA membership for 10 years prior to retirement, and who has a and membership is subject to Board A person with a specific interest continued personal interest in cancer approval. in oncology and with professional care is eligible as a retiree member, qualifications is eligible for admission subject to Board approval. 5 AFFILIATED AND as an ordinary member. ASSOCIATED ORGANISATIONS • Medical Member: Medical members 3 HONORARY MEMBERS Affiliated and Associated organisations are qualified clinical practitioners or A person who has made significant include not for profit companies, scientists with a specific interest in and sustained contributions to COSA institutions or organisations that have oncology. Medical members hold a or to cancer care in general is eligible a similar vision to COSA. 1 - 2 ANNUAL REPORT 2017 COSA BOARD + COSA REPORTS COSA GROUP REPORTS COSA BOARD AFFILIATED ORGANISATION REPORTS OTHER REPORTS FINANCIAL STATEMENTS Sandie Angus Phyllis Nick Director Butow AM Pavlakis (appointed 20 President President-Elect March 2018) Sanchia Christine Haryana Aranda Carrington Dhillon Director Director Director 3 - ANNUAL REPORT 2017 Peter Mei Sandra Dowding Krishnasamy McKiernan Director Director Director Felicity Shaw Wayne Director Nik Nicholls (retired 8 March Zeps Director 2018) Director Marie Malica Chief Executive Officer 3 - 4 ANNUAL REPORT 2017 COSA BOARD + COSA REPORTS COSA GROUP REPORTS AFFILIATED ORGANISATION REPORTS COSA COUNCIL OTHER REPORTS FINANCIAL STATEMENTS Council comprises the PRESIDENT Professor P Butow AM BA (Hons) Dip Ed MClinPsych MPH PhD President, President Elect, PRESIDENT ELECT Immediate Past President, A/Professor N Pavlakis BSc MBBS MMed (Clin.Epi) PhD FRACP Chair of each COSA Group and the nominee of each Affiliated Organisation. COSA GROUP REPRESENTATIVES ADOLESCENT AND YOUNG ADULT FAMILIAL CANCER GROUP PAEDEATRIC ONCOLOGY GROUP GROUP Chair: A/Professor N Pachter MBChB Chair: Position vacant Chair: Dr W Nicholls MBChB FRACP FRACP PALLIATIVE CARE GROUP Ms Lucinda Salmon BScm Grad Dip BREAST CANCER GROUP Chair: Professor J Phillips RN PhD Genetic Counselling FHGSA Chair: Dr S Fraser MBBS FASBP FACN GASTROINTESTINAL ONCOLOGY CANCER BIOLOGY GROUP PSYCHO-ONCOLOGY GROUP GROUP Chair: Professor N Zeps BSc (Hons) Chair: Dr L Kirsten DPsyc(Clinical) PhD Chair: Professor E Segelov MBBS PhD (Hons1) FRACP PhD RADIATION ONCOLOGY GROUP CANCER CARE COORDINATION Chair: Position Vacant GERIATRIC ONCOLOGY GROUP GROUP Chair: Professor M Agar MBBS FRACP RARE CANCERS GROUP Chair: Professor P Yates PhD RN FAAN FaChPM MPC PhD Chair: A/Professor C Scott MBBS PhD FACN FRACP GYNAECOLOGICAL ONCOLOGY CANCER PHARMACISTS GROUP GROUP REGIONAL & RURAL ONCOLOGY Chair: Mr M Powell BPharm Chair: Position vacant GROUP DipPharmPrac MSHP Chair: Professor S Sabesan INTEGRATIVE ONCOLOGY GROUP CANCER PREVENTION BMBS(Flinders) PhD FRACP Chair: Dr J Lacey MBBS FRACGP Professor B Stewart AM MSc PhD Dr R Zielinski MB.BS Hons (Sydney) BE FAChPM (FRACP) FRACI DipLaw GradDipLegalPract Hons (Sydney) LUNG CANCER GROUP CLINICAL TRIALS RESEARCH SURGICAL ONCOLOGY GROUP Chair: A/Professor N Pavlakis BSc PROFESSIONALS GROUP Chair: Position Vacant MBBS MMed (Clin.Epi) PhD FRACP Chair: Mrs D Lindsay BAppSc (Hons) SURVIVORSHIP GROUP MELANOMA AND SKIN GROUP EPIDEMIOLOGY GROUP Chair: Professor B Koczwara AM BM BS Chair: Dr D Speakman MBBS FRACS Chair: Dr H Tuffaha BPharm MBA MSci FRACP MBioethics FAICD PhD NEUROENDOCRINE TUMOURS UROLOGIC ONCOLOGY GROUP GROUP EXERCISE & CANCER GROUP Chair: Professor I Davis MBBS (Hons) Chair: Dr Y Chua FRACP Chair: A/Professor P Cormie PhD AEP PhD FRACP FAChPM Position vacant CONSUMER REPRESENTATIVE NEURO-ONCOLOGY GROUP Position vacant Chair: Dr ES Koh MBBS FRANZCR NUTRITION GROUP Chair: Dr N Kiss PhD Adv APD 5 - ANNUAL REPORT 2017 AFFILIATED ORGANISATION REPRESENTATIVES AUSTRALASIAN GASTRO-INTESTINAL AUSTRALIAN AND NEW ZEALAND MEDICAL ONCOLOGY GROUP OF TRIALS GROUP UROGENITAL & PROSTATE CANCER AUSTRALIA Professor T Price MBBS FRACP TRIALS GROUP Professor C Karapetis MBBS FRACP DHlthSc (Medicine) Professor I Davis MBBS (Hons) PhD MMedSc FRACP FAChPM AUSTRALASIAN LEUKAEMIA & MELANOMA AND SKIN CANCER LYMPHOMA GROUP AUSTRALIA NEW ZEALAND TRIALS LIMITED GYNAECOLOGICAL ONCOLOGY Professor M Shackleton MBBS PhD (Jan-May) Professor M Hertzberg MBBS GROUP FRACP PhD FRACP FRCPA (Jan-Apr) A/Professor A Brand MD (May-Dec) A/Professor P Mollee ONCOLOGY SOCIAL WORK MMEd FRCS(C) FRANZCOG CGO MBBS(Hons) MMedSc FRACP FRCPA AUSTRALIA (Apr-Dec) A/Professor P Beale BSc Ms K Hobbs MSW MAASW AUSTRALASIAN LUNG CANCER MBBS FRACP PhD TRIALS GROUP PRIMARY CARE COLLABORATIVE BREAST CANCER TRIALS A/Professor N Pavlakis BSc MBBS CANCER CLINICAL TRIALS GROUP Professor G B Mann MBBS PhD FRACS MMed (Clin.Epi) PhD FRACP (Jan-Oct) Professor L Trevena CANCER NURSES SOCIETY OF MBBS(Hons) MPhilPH PhD AUSTRALASIAN METASTASIS AUSTRALIA (Oct-Dec) A/professor J Rhee BSc(Med) RESEARCH SOCIETY (Jan-Jun): Ms J Campbell CCN MBBS(Hons) GCULT PhD FRACGP Professor E Thompson PhD (Jun-Dec): Ms C O’Kane Cancer Nurse PSYCHO-ONCOLOGY COOPERATIVE AUSTRALIA AND NEW ZEALAND Practitioner RESEARCH GROUP SARCOMA ASSOCIATION CANCER SYMPTON TRIALS and (Jan-May) Dr J Couper MBBS MD Dr J Desai MBBS FRACP PALLIATIVE CARE CLINICAL STUDIES MMed(psych) FRANZCP AUSTRALIAN & NEW ZEALAND COLLABORATIVE (May-Dec) Dr J Shaw BApplSc CHILDRENS HAEMATOLOGY Dr P Allcroft BMBS FRACP M Pall Care BPsych(Hons) PhD ONCOLOGY GROUP COOPERATIVE TRIALS GROUP FOR ROYAL COLLEGE OF PATHOLOGISTS Dr C Fraser FRACP MBBS MPH NEURO-ONCOLOGY OF AUSTRALASIA AUSTRALIAN AND NEW ZEALAND Professor A Nowak MBBS FRACP PhD Dr K Lee MB ChB FRCPA HEAD & NECK CANCER SOCIETY FACULTY OF RADIATION ONCOLOGY TROG CANCER RESEARCH A/Professor M Batstone MBBS Dr D Forstner MBBS (Hons) FRANZCR Dr P Sundaresan BSc(Hons) MBBS BDSc(Hons) MPhil(Surg) FRACDS(OMS) FRANZCR PhD FRCA(OMFS) HUMAN GENETICS SOCIETY OFAUSTRALASIA AUDITORS (Jan-Mar) Ms M Young GradDip SocSci BDO (Fam Therapy) MHSc (Gen Couns) Level 11 FHGSA 1 Margaret St (Mar-Dec) A/Professor N Pachter Sydney NSW 2000 MBChB FRACP 5 - 6 ANNUAL REPORT 2017 COSA BOARD + COSA REPORTS COSA GROUP REPORTS AFFILIATED ORGANISATION REPORTS REPORT OF THE PRESIDENTOTHER REPORTS FINANCIAL STATEMENTS I am pleased to Achievements in 2018 was returning home to Perth after attending the COSA ASM in Sydney. present my second Some of our noteworthy achievements Paul was a beloved member of the and final annual report in 2018 include: cancer community, especially of COSA. Many members of Paul’s family and contribution as COSA Financial surplus against a Board colleagues from Cancer Council WA approved small budget deficit President. I am proud to attended the opening so they could say COSA continues to The official launch of the COSA witness us honouring Paul in this hold high standing in the Exercise in Cancer Care position small way.
Load more

Recommended publications
  • Michael Green CV
    Election – ESMO National Representative 2015-2016 Professor Michael Green Western Health Melbourne; Australia Australia as an integral member of the Asia-Pacific region has a responsibility to assist in the improvement of cancer outcomes in the region. This requires active representation on scholarly bodies as well as government and non-government organizations to assist in the transfer of skills via education as well as clinical trials. As a long-time member of ESMO as well as other international organizations with a strong interest in teaching, training and communication I believe I can contribute to this objective. Education 1967 - 1972 M.B.B.S., University of Melbourne 1982 FRACP (Royal Australasian College of Physicians) 1988 FACP (American College of Physicians) Degrees M.B.B.S; FRACP Specialisation Medical Oncology Professional Experience 2010 – today: Professor, Department of Medicine, University of Melbourne 2009: Director Cancer Services, Western Health Victoria Consultant Medical Oncologist Melbourne Health 1997-2010: Associate Professor, Department of Medicine, University of Melbourne 1990: Director Department of Haematology, Medical Oncology and Palliative Care, Western Hospital 1987-2009: Deputy Director, Department of Clinical Haematology and Medical Oncology, The Royal Melbourne Hospital 1987-1997: Associate Member, Department of Medicine, University of Melbourne 1984-1987: Assistant Professor, Department of Medicine, Division of Oncology New York University Medical Center, U.S.A. 1983-1987: Director of Developmental Therapeutics Program, Rita & Stanley H Kaplan Cancer Center, New York University Medical Center, U.S.A. 1982-1984: Instructor, Department of Medicine, New York University Medical Center, U.S.A. 1980-1982: Fellow in Clinical Oncology, Division of Oncology, New York University Medical Center, U.S.A.
    [Show full text]
  • 2013 Research Report
    RESEARCH >REPORT St George and Sutherland Hospitals 2012 » 2013 > INTRODUCTIONS Professor John Edmonds Conjoint Professor, UNSW Chair of the St George and Sutherland Medical Research Foundation The Research Report of the St George and Sutherland Hospitals, currently published every second year, is an important record of our clinical and research staff and some traditional indicators by which institutions’ research status is judged: projects undertaken, grants awarded, publications and presentations. There are encouraging pointers, great and small, that government and society are increasingly recognising the importance of medical research: McKeon’s Strategic Review of Health and Medical Research; a federal commitment to a 20 billion dollar medical research fund; the choice of Suzanne Corey (former Director of WEHI) as the 2014 Boyer Lecturer; even a recent Q & A session devoted to Science & Australia. As society looks to its great academic medical centres for research-driven guidance, it becomes ever more important that St George and Sutherland Hospitals match the excellence of their clinical service and teaching with a comparable level of eminence in research endeavour and success. The St George and Sutherland Medical Research Foundation is committed to helping the hospitals’ academics in that project. The Research Reports provide a useful audit of our joint progress. Professor Peter Gonski Head, Sutherland Teaching Unit St George Clinical School Although Sutherland Hospital is well known as a provider of major clinical service to the South Eastern Sydney Local Health District, it also provides a major teaching resource to medical, nursing and allied health students. Research is now becoming important in its activities. On behalf of Sutherland, I am grateful that the St George and Sutherland Medical Research Foundation has included us in their activities and also providing research funds.
    [Show full text]
  • Cancer Forum
    Cancer Forum March 2003 Volume 27 Number 1 ISSN 0311-306X List of Contents Forum: Clinical trials Overview 3 M Stockler Clinical trials: Benefits and challenges 4 A Coates We’ve got a groovy thing goin’ baby … or have we? Involving women in clinical trials 5 S Lockwood Maximising opportunities for clinical research: The Centre for Developmental Cancer Therapeutics 7 MA Rosenthal HERA – new lessons from a new trial 8 N Wilcken Cancer Trials NSW: A collaborative initiative to support and promote cancer clinical trials research in NSW 9 M Malica Australian New Zealand Breast Cancer Trials Group: IMPACT 11 L Young Articles Testing for familial cancer susceptibility gene mutations 13 A Rowland, N Breheny, J Goldblatt , I Walpole, P O’Leary The impact of physiotherapy intervention on functional independence and quality of life in palliative patients 15 EL Laakso, AJ McAuliffe, A Cantlay Reports Support for research 2003 21 From bench to bedside and back again: COSA 29th Annual Scientific Meeting 30 Clinical trials: An open forum for consumers 31 Australian Behavioural Research in Cancer 32 News and Announcements 37 Book Reviews 41 Calendar of Meetings 47 F Clinical trials: How consumers, clinicians ORUM and researchers can initiate and participate in the best cancer trials OVERVIEW M Stockler Clinical Trials Symposium held at Darling Harbour, Sydney in 2002. Co-Director of Cancer Trials, NHMRC Clinical Trials Centre, University of Alan Coates sets the scene by describing the benefits, Sydney beneficiaries and challenges of cancer clinical trials research. Senior Lecturer in He concludes that cancer trials are a good buy for patients, Cancer Medicine and doctors and society.
    [Show full text]
  • Clinical Practice Guidelines for the Management of Early Breast Cancer: Second Edition
    CLINICAL PRACTICE GUIDELINES CLINICAL PRACTICE CLINICAL PRACTICE GUIDELINES Management of early breast cancer Management of early breast cancer of early breast Management NHMRC National Health & Medical Research Council Clinical practice guidelines for the management of early breast cancer: Second edition Prepared by the iSource National Breast Cancer Centre Endorsed August 2001 NHMRC National Health & Medical Research Council Clinical practice guidelines for the management of early breast cancer i © Commonwealth of Australia 2001 ISBN Print: 1864960876 Online: 1864960930 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from AusInfo. Requests and enquiries concerning reproduction and rights should be addressed to the Manager, Legislative Services, AusInfo, GPO Box 1920, Canberra ACT 2601. Email address: [email protected] The strategic intent of the NHMRC is to provide leadership and work with other relevant organisations to improve the health of all Australians by: • fostering and supporting a high quality and internationally recognised research base; • providing evidence based advice; • applying research evidence to health issues thus translating research into better health practice and outcomes; and • promoting informed debate on health and medical research, health ethics and related issues. This document was prepared by the iSource National Breast Cancer Centre Early Breast Cancer Working Group. This document is a general guide to appropriate practice, to be followed only subject to the clinician’s judgement and the woman’s preference in each individual case. The guidelines are designed to provide information to assist decision-making and are based on the best information available at the time of publication.
    [Show full text]
  • Cancer Forum
    May 2006 Volume 30 Number 2 ISSN 0311-306X CANCER FORUM Contents nnn Forum: Progress in cancer control: the Alan Coates effect Alan Coates: an appreciation 95 William McCarthy Progress in cancer control: the Alan Coates effect 96 Ian Frazer and Richard Kefford Alan Coates and The Cancer Council Australia 98 Ray Lowenthal “Know your PSA”: not always good advice 101 Ian Tannock The surgical management of cutaneous melanoma: have we made any real progress 103 in 100 years? John Thompson and Helen Shaw Mapping the human body: the importance of cross-disciplinary thinking 107 Andrew Coates Melanoma: narrowing the sights on an evasive enemy 110 Richard Kefford Harnessing the immune system to prevent cervical cancer 115 Ian Frazer The Australia New Zealand Breast Cancer Trials Group: some contributions 118 to breast cancer trials John Forbes Local therapy in a systemic world: the evolution and incarnations of 121 adjuvant radiotherapy for breast cancer Susan Pendlebury Antiemetic research: solving patient problems 123 Ian Olver On the receiving end: cancer patients’ perceptions of the burden of chemotherapy 126 Martin Tattersall Quality of life research that shaped oncologists’ thinking and practice 128 Martin Stockler nnn Reports COSA, Cancer Council call for cancer training improvements in medical education inquiry 130 Lorne Cancer Conference 131 Australian behavioural research in cancer 133 nnn News and announcements 138 nnn Book reviews 141 nnn Calendar of meetings 151 CancerForum Volume 30 Number 2 May 2006 93 CANCER FORUM FORUM Progress in cancer control: the Alan Coates effect ALAN COATES: AN APPRECIATION William McCarthy AM n Email: [email protected] The last 50 years have seen major changes in cancer management.
    [Show full text]